Search clinical trials for: anti-PD-L1 monoclonal antibody
Total 104059 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Malignant Solid Neoplasm | Stage IV Colon Cancer AJCC v8 | Stage IV Rectal Cancer AJCC v8 | Stage IVA Colon Cancer AJCC v8 | Stage IVA Rectal Cancer AJCC v8 | Stage IVB Colon Cancer AJCC v8 | Stage IVB Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Colon Adenocarcinoma | High-Frequency Microsatellite... and other conditionsUnited States
-
St. Jude Children's Research HospitalPfizer; Gateway for Cancer ResearchCompletedOsteosarcomaUnited States
-
University of ChicagoWithdrawnHead and Neck CancerUnited States
-
Radiopharm Theranostics, LtdRecruitingNon Small Cell Lung Cancer | PDL1 Gene MutationAustralia
-
Shanghai Chest HospitalRecruitingNon-Small Cell Lung CancerChina
-
Institut Claudius RegaudActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Marker Therapeutics, Inc.Completed
-
Fox Chase Cancer CenterGenentech, Inc.Active, not recruitingHER2-positive Breast CancerUnited States
-
Chinese PLA General HospitalRecruitingHodgkin Lymphoma | Anti-PD-1 Antibody ResistantChina
-
Guru SonpavdePfizer; Hoosier Cancer Research NetworkWithdrawnKidney Cancer | Clear-cell Renal Cell Carcinoma | RCC | Clear-cell Kidney CarcinomaUnited States
-
Gruppo Oncologico del Nord-OvestRecruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Merck Sharp & Dohme LLCRecruitingBladder CancerCanada, France, Italy, Netherlands, Turkey, Brazil, Spain, United States, Finland, Puerto Rico, Singapore
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast NeoplasmsBrazil, Canada, United States, United Kingdom, Taiwan, Australia, Colombia, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Poland, Portugal, Russian Federation, Singapore, Spain, Sweden, Turkey
-
Merck Sharp & Dohme LLCCompleted
-
Shanghai Cancer Hospital, ChinaUnknownLung Cancer Stage IV，EGFR-mutant，TKI，PD-L1，SBRTChina
-
Kidney Cancer Research BureauRecruitingMetastatic Gastric Cancer | FGFR2 Amplification | PD-L1 Gene AmplificationUnited States
-
Megan Daly, MDNational Cancer Institute (NCI); Genentech, Inc.TerminatedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Instituto Nacional de Cancerologia de MexicoUnknownNon-Small Cell Lung CancerMexico
-
Lee's Pharmaceutical LimitedActive, not recruiting
-
Second Affiliated Hospital of Soochow UniversitySciClone PharmaceuticalsRecruitingAdvanced Solid Tumor | Refractory TumorChina
-
Consorzio OncotechActive, not recruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | PD-L1 Gene MutationItaly
-
The First Affiliated Hospital of Zhengzhou UniversityRecruiting
-
Cairo UniversityNot yet recruiting
-
Merck Sharp & Dohme LLCActive, not recruitingNeoplasmsPoland, United States, Australia, Canada, China, France, Greece, Israel, Japan, Korea, Republic of, South Africa, Spain
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCActive, not recruitingHodgkin's Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL)Canada, United States, Brazil, Czechia, France, Italy, Poland, Russian Federation, South Africa, Turkey, Ukraine
-
Merck Sharp & Dohme LLCCompletedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Multiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Primary Mediastinal B-Cell Lymphoma
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCTerminated
-
Melinta Therapeutics, Inc.Completed
-
University Medical Center GroningenCompleted
-
Cancer Research UKHeptares Therapeutics LimitedRecruitingSarcoma | Neoplasms | Kidney Neoplasms | Uterine Cervical Neoplasms | Stomach Neoplasms | Head and Neck Neoplasms | Lung Neoplasms | Urinary Bladder Neoplasms | Colorectal Neoplasms | Pancreatic Neoplasms | Esophageal Neoplasms | Mesothelioma, Malignant | Prostatic Neoplasms, Castration-Resistant | PheochromocytomasUnited Kingdom
-
Peking UniversityNot yet recruiting
-
Radboud University Medical CenterAstraZenecaCompletedHead and Neck CancerNetherlands
-
MedImmune LLCCompletedDiffuse Large B-Cell LymphomaUnited States, France, United Kingdom, Ireland
-
Elpiscience Biopharma, Ltd.WithdrawnSmall Cell Lung Cancer | Non-small Cell Lung Cancer | Thoracic Tumors
-
Joachim Aerts, MD PhDAIM ImmunoTech Inc.; AstraZeneca BVRecruiting
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Shirish M GadgeelAstraZeneca; Henry Ford Health SystemWithdrawnLung Cancer | Non-small Cell Lung Cancer | PD-L1 Gene Mutation | KRAS Activating MutationUnited States
-
Dragonboat Biopharmaceutical Company LimitedWest China HospitalRecruitingAdvanced Malignant TumorChina
-
Laekna LimitedRecruitingCervical Cancer | Esophageal Cancer | NSCLC | Solid Tumor | Endometrial Cancer | Gastric and Gastroesophageal Junction AdenocarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Malignant Tumors LymphomasUnited States
-
ETOP IBCSG Partners FoundationGlaxoSmithKline; Development LimitedRecruitingSCLC,Extensive Stage | SLFN11-positiveSwitzerland, France, Spain, Italy
-
Kiang Wu HospitalCompleted
-
UNICANCERAstraZeneca; National Cancer Institute, France; Pierre Fabre LaboratoriesActive, not recruitingBreast Cancer | Head and Neck Cancer | Prostate Cancer | Cervix Cancer | Advanced Solid TumoursFrance
-
BeiGeneRecruitingNon-Small Cell Lung CancerChina, Korea, Republic of
-
3D Medicines (Sichuan) Co., Ltd.CompletedSolid TumorsUnited States